Prostaglandin E2 synthesis and suppression of fibroblast proliferation by alveolar epithelial cells is cyclooxygenase-2-dependent

American Journal of Respiratory Cell and Molecular Biology

Volumn 27, Issue 6, 2002, Pages 752-758

  Lama, Vibha ^a,b   Moore, Bethany B ^a,b   Christensen, Paul ^a,b   Toews, Galen B ^a,b   Peters Golden, Marc ^a,b,c  

^a UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

^b VA ANN ARBOR HEALTHCARE SYSTEM   (United States)

^c 6301 MSRB III ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMALIA; MURINAE;

CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; ISOENZYME; MEMBRANE PROTEIN; PROSTAGLANDIN E2; PROSTAGLANDIN SYNTHASE; PTGS1 PROTEIN, MOUSE;

ANIMAL; ARTICLE; BIOSYNTHESIS; C57BL MOUSE; CELL COMMUNICATION; CELL CULTURE; CELL DIVISION; COCULTURE; CYTOLOGY; ENZYMOLOGY; FIBROBLAST; GENETICS; GENOTYPE; LUNG ALVEOLUS; LUNG FIBROSIS; METABOLISM; MOUSE; MOUSE MUTANT; PHYSIOLOGY; RESPIRATORY TRACT MUCOSA;

ANIMALS; CELL COMMUNICATION; CELL DIVISION; CELLS, CULTURED; COCULTURE TECHNIQUES; CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; DINOPROSTONE; FIBROBLASTS; GENOTYPE; ISOENZYMES; MEMBRANE PROTEINS; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES; PULMONARY ALVEOLI; PULMONARY FIBROSIS; RESPIRATORY MUCOSA;

EID: 0036882114     PISSN: 10441549     EISSN: None     Source Type: Journal    
DOI: 10.1165/rcmb.4857     Document Type: Article

References (57)

1. Mason, R., M. Schwarz, G. Hunninghake, and R. Musson. 1999. NHLBI Workshop Summary. Pharmacological therapy for idiopathic pulmonary fibrosis: Past, present, and future. Am. J. Respir. Crit. Care Med. 160:1771-1777.
2. Selman, M., T. King, Jr., and A. Pardo. 2001. Idiopathic pulmonary fibrosis: Prevailing and evolving hypotheses about its pathogenesis and implications for therapy. Ann. Intern. Med. 134:136-151.
3. Brody, A., P. Soler, F. Basset, W. Haschek, and H. Witschi. 1981. Epithelial-mesenchymal associations of cells in human pulmonary fibrosis and in BHT-oxygen-induced fibrosis in mice. Exp. Lung Res. 2:207-220.
4. Kawanami, O., V. Ferrans, and R. Crystal. 1982. Structure of alveolar epithelial cells in patients with fibrotic lung disorders. Lab. Invest. 46:39-53.
5. Haschek, W., and H. Witschi. 1979. Pulmonary fibrosis: A possible mechanism. Toxicol. Appl. Pharmacol. 51:475-487.
6. Adamson, I., L. Young, and D. Bowden. 1988. Relationship of alveolar epithelial injury and repair to the induction of pulmonary fibrosis. Am. J. Pathol. 130:377-386.
7. Klien, J. H., and I. Y. R. Adamson. 1989. Fibroblast inhibition and prostaglandin secretion by alveolar epithelial cells exposed to silica. Lab. Invest. 60:808-813.
8. Pan, T., R. Mason, J. Westcott, and J. Shannon. 2001. Rat alveolar type II cells inhibit lung fibroblast proliferation in vitro. Am. J. Respir. Cell Mol. Biol. 25:353-361.
9. 2 inhibits fibroblast chemotaxis. Am. J. Physiol. Lung Cell. Mol. Physiol. 281:L1257-L1263.
10. Bitterman, P., M. Wewers, S. Rennard, S. Adelberg, and R. Crystal. 1986. Modulation of alveolar macrophage-driven fibroblast proliferation by alternative macrophage mediators. J. Clin. Invest. 77:700-708.
11. Elias, J., M. Rossman, R. Zurier, and R. Daniele. 1985. Human alveolar macrophage inhibition of lung fibroblast growth: A prostaglandin-dependent process. Am. Rev. Respir. Dis. 131:94-99.
12. Korn, J., P. Halushka, and E. Leroy. 1980. Mononuclear cell modulation of connective tissue function: Suppression of fibroblast growth by stimulation of endogenous prostaglandin production. J. Clin. Invest. 65:543-554.
13. Goldstein, R., and P. Polgar. 1982. The effect and interaction of bradykinin and prostaglandins on protein and collagen production by lung fibroblasts. J. Biol. Chem. 257:8630-8633.
14. Moore, B., M. Coffey, P. Christensen, S. Sitterding, R. Ngan, C. Wilke, R. McDonald, S. Phare, M. Peters-Golden, R. Paine, and G. Toews. 2000. GM-CSF regulates bleomycin-induced pulmonary fibrosis via a prostaglandin-dependent mechanism. J. Immunol. 165:4032-4039.
15. Keerthisingam, C., R. Jenkins, N. Harrison, N. Hernandez-Rodriguez, H. Booth, G. Laurent, S. Hart, M. Foster, and R. McAnulty. 2001. Cyclooxygenase-2 deficiency results in a loss of the anti-proliferative response to transforming growth factor-β in human fibrotic lung fibroblasts and promotes bleomycin-induced fibrosis in mice. Am. J. Pathol. 158:1411-1422.
16. Chauncey, J., M. Peters-Golden, and R. Simon. 1988. Arachidonic acid metabolism by rat alveolar epithelial cells. Lab. Invest. 58:133-140.
17. Cott, G., J. Westcott, and N. Voelkel. 1990. Prostaglandin and leukotriene production by alveolar type II cells in vitro. Am. J. Physiol. (Lung Cell Mol. Physiol.) 258:L179-L187.
18. van Overveld, F. J., P. G. Jorens, W. A. De Backer, M. Rampart, L. Bossaert, and P. A. Vermeire. 1992. Release of arachidonic acid metabolites from isolated human alveolar type II cells. Prostaglandins 44:101-110.
19. Dubois, R., S. Abramson, L. Crofford, R. Gupta, L. Simon, L. Van De Putte, and P. Lipsky. 1998. Cyclooxygenase in biology and disease. FASEB J. 12:1063-1073.
20. Asano, K., C. Lilly, and J. Drazen. 1996. Prostaglandin G/H synthase-2 is the constitutive and dominant isoform in cultured human lung epithelial cells. Am. J. Physiol. 271:L126-L131.
21. Walenga, R., M. Kester, E. Coroneos, S. Butcher, R. Dwivdi, and C. Statt. 1996. Constitutive expression of prostaglandin endoperoxide G/H synthetase (PGHS)-2 but not PGHS-1 in human tracheal epithelial cells in vitro. Prostaglandins 52:341-359.
22. Wardlaw, S., T. March, and S. Belinsky. 2000. Cyclooxygenase-2 expression is abundant in alveolar type II cells in lung cancer-sensitive mouse strains and in premalignant lesions. Carcinogenesis 21:1371-1377.
23. Langenbach, R., S. Morham, H. Tiano, C. Loftin, B. Ghanayem, P. Chulada, J. Mahler, C. Lee, E. Goulding, K. Kluckman, H. Sim, and O. Smithies. 1995. Prostaglandin synthase 1 gene disruption in mice reduces arachidonic acid-induced inflammation and indomethacin-induced gastric ulceration. Cell 83:483-492.
24. Morham, S., R. Langenbach, C. Loftin, H. Tiano, N. Vouloumanos, J. Jennette, J. Mahler, K. Kluckmam, A. Ledford, C. Lee, and O. Smithies. 1995. Prostaglandin synthase 2 gene disruption causes severe renal pathology in the mouse. Cell 83:473-482.
25. Corti, M., A. Brody, and J. Harrison. 1996. Isolation and primary culture of murine alveolar type II cells. Am. J. Respir. Cell Mol. Biol. 14:309-315.
26. Smith, W., and T. Rollins. 1982. Characteristics of rabbit anti-PGH synthase antibodies and use in immunochemistry. Methods Enzymol. 86:213-222.
27. Leslie, C., K. McCormick-Shannon, R. Mason, and J. Shannon. 1993. Proliferation of rat alveolar epithelial cells in low density primary culture. Am. J. Respir. Cell Mol. Biol. 9:64-72.
28. Young, L., and I. Adamson. 1993. Epithelial-fibroblast interactions in bleomycin-induced lung injury and repair. Environ. Health Perspect. 101:56-61.
29. 2 and to express cyclooxygenase-2. J. Clin. Invest. 95:1861-1868.
30. Lin, C., S. Sheu, H. Lee, Y. Ho, W. Lee, W. Ko, and J. Sheu. 2000. Involvement of protein kinase C-gamma in IL-1 beta-induced cyclooxygenase-2 expression in human pulmonary epithelial cells. Mol. Pharmacol. 57:36-43.
31. Lehmann, J., J. Lenhard, B. Oliver, G. Ringold, and S. Kliewer. 1997. Peroxisome proliferator-activated receptors α and γ are activated by indomethacin and other non-steroidal anti-inflammatory drugs. J. Biol. Chem. 272:3406-3410.
32. 2 counteracts interleukin-1β-stimulated upregulation of platelet-derived growth factor α-receptor on rat pulmonary myofibroblasts. Am. J. Respir. Cell Mol. Biol. 20:433-440.
33. 2. Am. J. Physiol. 277:L1165-L1171.
34. Riquet, F., W. Lai, J. Birkhead, L. Suen, G. Karsenty, and M. Goldring. 2000. Suppression of type I collagen gene expression by prostaglandins in fibroblasts is mediated at the transcriptional level. Mol. Med. 6:705-719.
35. Baum, B., S. Moss, R. Breul, and R. Crystal. 1980. Effect of cyclic AMP an the intracellular degradation of newly synthesized collagen. J. Biol. Chem. 255:2843-2847.
36. Saltzman, L., J. Moss, R. Berg, B. Hom, and R Crystal. 1982. Modulation of collagen production by fibroblasts: Effects of chronic exposure to agonists that increase intracellular cyclic AMP. Biochem. J. 204:25-30.
37. Stratton, R., X. Shiwen, G. Martini, A. Holmes, A. Leask, T. Haberberger, G. Martin, C. Black, and D. Abraham. 2001. Iloprost suppresses connective tissue growth factor production in fibroblasts and in the skin of scleroderma patients. J. Clin. Invest. 108:241-250.
38. 2 biosynthesis in cyclooxygenase 1 or 2 null cells. J. Exp. Med. 187:517-523.
39. Wollin, L., S. Uhlig, R. Nusing, and A. Wendel. 2001. Granulocyte-macrophage colony-stimulating factor amplifies lipopolysaccharide-induced bronchoconstriction by a neutrophil- and cyclooxygenase 2-dependent mechanism. Am. J. Respir. Crit. Care Med. 163:443-450.
40. Gavett, S., S. Madison, P. Chulada, P. Scarborough, W. Qu, J. Boyle, H. Tiano, C. Lee, R. Langenbach, V. Roggli, and D. Zeldin. 1999. Allergic lung responses are increased in prostaglandin H synthase-deficient mice. J. Clin. Invest. 104:721-732.
41. Dowd, N., M. Scully, S. Adderley, A. Cunningham, and D. Fitzgerald. 2001. Inhibition of cyclooxygenase-2 aggravates doxorubicin-mediated cardiac injury in vivo. J. Clin. Invest. 108:585-590.
42. Reilly, T., J. Brady, M. Marchick, M. Bourdi, J. George, M. Radonovich, C. Pise-Masison, and L. Pohl. 2001. A protective role for cyclooxygenase-2 in drug-induced liver injury in mice. Chem. Res. Toxicol. 14:1620-1628.
43. Gilroy, D., P. Colville-Nash, D. Willis, J. Chivers, J. Paul-Clark, and D. Willoughby. 1999. Inducible cyclooxygenase may have anti-inflammatory properties. Nat. Med. 5:698-701.
44. Morteau, O., S. Morham, R. Sellon, L. Dieleman, R. Langenbach, O. Smithies, and R. Sartor. 2000. Impaired mucosal defense to acute colonic injury in mice lacking cyclooxygenase-1 or cyclooxygenase-2. J. Clin. Invest. 105:469-478.
45. Harris, R., J. McKanna, Y. Akai, H. Jacobson, R. Dubois, and M. Breyer. 1994. Cyclooxygenase-2 is associated with the macula densa of rat kidney and increases with salt restriction. J. Clin. Invest. 94:2504-2510.
46. Yamagata, K., K. Andreasson, W. Kaufmann, C. Barnes, and P. Worley. 1993. Expression of a mitogen-inducible cyclooxygenase in brain neurons: Regulation by synaptic activity and glucocorticoids. Neuron 11:371-386.
47. McAdam, B., F. Catella-Lawson, I. Mardini, S. Kapoor, J. Lawson, and G. FitzGerald. 1999. Systemic biosynthesis of prostacyclin by cyclooxygenase (COX)-2: The human pharmacology of a selective inhibitor of COX-2. Proc. Natl. Acad. Sci. USA 96:272-277.
48. 2 production in human monocytes: Implications for the use of cyclooxygenase inhibitors. J. Immunol. 165:1605-1611.
49. 2 in activated mast cells. J. Biol. Chem. 272:3231-3237.
50. 2, cyclooxygenases, and terminal prostanoid synthases in different phases of prostanoid biosynthesis in rat peritoneal macrophages. J. Immunol. 160:2974-2982.
51. 2. J. Biol. Chem. 274:11660-11666.
52. McAnulty, R., N. Hernandez-Rodriguez, S. Mutsaers, R. Coker, and G. Laurent. 1997. Indomethacin suppresses the anti-proliferative effects of transforming growth factor-beta isoforms on fibroblast cell cultures. Biochem. J. 321:639-643.
53. 2 production in normal and fibrotic lung fibroblasts. Am. J. Respir. Cell Mol. Biol. 22:628-634.
54. Christensen, P., M. Bailie, R. Goodman, A. O'Brien, G. Toews, and R. I. Paine. 2000. Role of diminished epithelial GM-CSF in the pathogenesis of bleomycin-induced pulmonary fibrosis. Am. J. Physiol. Lung Cell. Mol. Physiol. 279:L487-L495.
55. Frank, J., J. Gutierrez, K. Jones, L. Allen, L. Dobbs. and M. Matthay. 2002. Low tidal volume reduces epithelial and endothelial injury in acid-injured rat lungs. Am. J. Respir. Crit. Care Med. 165:242-249.
56. 2 production during airway obstruction in an animal model of asthma. Am. Rev. Respir. Dis. 146:586-591.
57. Picado, C., J. Fernandez-Morata, M. Juan, J. Roca-Ferrer, M. Fuentes, A. Xaubet, and J. Mullol. 1999. Cyclooxygenase-2 mRNA is downexpressed in nasal polyps from aspirin-sensitive asthmatics. Am. J. Respir. Crit. Care Med. 160:291-296.